These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 2904784

  • 1. Neuroleptic binding to human brain receptors: relation to clinical effects.
    Richelson E.
    Ann N Y Acad Sci; 1988; 537():435-42. PubMed ID: 2904784
    [Abstract] [Full Text] [Related]

  • 2. Pharmacology of neuroleptics in use in the United States.
    Richelson E.
    J Clin Psychiatry; 1985 Aug; 46(8 Pt 2):8-14. PubMed ID: 2862140
    [Abstract] [Full Text] [Related]

  • 3. Preclinical pharmacology of neuroleptics: focus on new generation compounds.
    Richelson E.
    J Clin Psychiatry; 1996 Aug; 57 Suppl 11():4-11. PubMed ID: 8941166
    [Abstract] [Full Text] [Related]

  • 4. Relationship of neuroleptic drug effects at brain dopamine, serotonin, alpha-adrenergic, and histamine receptors to clinical potency.
    Peroutka SJ, Synder SH.
    Am J Psychiatry; 1980 Dec; 137(12):1518-22. PubMed ID: 6108081
    [Abstract] [Full Text] [Related]

  • 5. Relative affinities for different classes of neurotransmitter receptors predict neuroleptic efficacy in infantile autism: a hypothesis.
    Deutsch SI, Campbell M.
    Neuropsychobiology; 1986 Dec; 15(3-4):160-4. PubMed ID: 2431345
    [Abstract] [Full Text] [Related]

  • 6. Neuroleptic affinities for human brain receptors and their use in predicting adverse effects.
    Richelson E.
    J Clin Psychiatry; 1984 Aug; 45(8):331-6. PubMed ID: 6146602
    [Abstract] [Full Text] [Related]

  • 7. The pharmacology of antidepressants at the synapse: focus on newer compounds.
    Richelson E.
    J Clin Psychiatry; 1994 Sep; 55 Suppl A():34-9; discussion 40-1, 98-100. PubMed ID: 7961541
    [Abstract] [Full Text] [Related]

  • 8. Neuropharmacology of zotepine, an antimanic drug: a potent blocker of D2 and 5-HT2 receptors of human brain.
    Kanba S, Yagi G, Oguchi E, Nakaki T, Kato R, Richelson E.
    Jpn J Psychiatry Neurol; 1991 Mar; 45(1):133-4. PubMed ID: 1684393
    [No Abstract] [Full Text] [Related]

  • 9. Antipsychotic drugs: prediction of side-effect profiles based on neuroreceptor data derived from human brain tissue.
    Black JL, Richelson E.
    Mayo Clin Proc; 1987 May; 62(5):369-72. PubMed ID: 2883343
    [Abstract] [Full Text] [Related]

  • 10. Receptor pharmacology of neuroleptics: relation to clinical effects.
    Richelson E.
    J Clin Psychiatry; 1999 May; 60 Suppl 10():5-14. PubMed ID: 10340682
    [Abstract] [Full Text] [Related]

  • 11. [Neuroleptics in geriatrics. Pharmacological criteria for a responsible choice and a correct use].
    van Wielink PS.
    Tijdschr Gerontol Geriatr; 1984 Apr; 15(2):73-80. PubMed ID: 6144201
    [Abstract] [Full Text] [Related]

  • 12. From anti-allergic to anti-Alzheimer's: Molecular pharmacology of Dimebon.
    Okun I, Tkachenko SE, Khvat A, Mitkin O, Kazey V, Ivachtchenko AV.
    Curr Alzheimer Res; 2010 Mar; 7(2):97-112. PubMed ID: 19939222
    [Abstract] [Full Text] [Related]

  • 13. [Role of dopamine receptors in the mechanism of action of neuroleptics].
    Lavretskaia EF, Kats MM, Baldenkov GN.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1985 Mar; 85(3):431-5. PubMed ID: 2859724
    [Abstract] [Full Text] [Related]

  • 14. Affinity of cyamemazine metabolites for serotonin, histamine and dopamine receptor subtypes.
    Benyamina A, Arbus C, Nuss P, Garay RP, Neliat G, Hameg A.
    Eur J Pharmacol; 2008 Jan 14; 578(2-3):142-7. PubMed ID: 17936750
    [Abstract] [Full Text] [Related]

  • 15. Antagonism by neuroleptics of neurotransmitter receptors of normal human brain in vitro.
    Richelson E, Nelson A.
    Eur J Pharmacol; 1984 Aug 17; 103(3-4):197-204. PubMed ID: 6149136
    [Abstract] [Full Text] [Related]

  • 16. Pharmacology of N-desmethylclozapine.
    Lameh J, Burstein ES, Taylor E, Weiner DM, Vanover KE, Bonhaus DW.
    Pharmacol Ther; 2007 Aug 17; 115(2):223-31. PubMed ID: 17583355
    [Abstract] [Full Text] [Related]

  • 17. Effects of remoxipride and some related new substituted salicylamides on rat brain receptors.
    Hall H, Sällemark M, Jerning E.
    Acta Pharmacol Toxicol (Copenh); 1986 Jan 17; 58(1):61-70. PubMed ID: 2869639
    [Abstract] [Full Text] [Related]

  • 18. Affinity of cyamemazine, an anxiolytic antipsychotic drug, for human recombinant dopamine vs. serotonin receptor subtypes.
    Hameg A, Bayle F, Nuss P, Dupuis P, Garay RP, Dib M.
    Biochem Pharmacol; 2003 Feb 01; 65(3):435-40. PubMed ID: 12527336
    [Abstract] [Full Text] [Related]

  • 19. A new arylpiperazine antipsychotic with high D2/D3/5-HT1A/alpha 1A-adrenergic affinity and a low potential for extrapyramidal effects.
    Reitz AB, Bennett DJ, Blum PS, Codd EE, Maryanoff CA, Ortegon ME, Renzi MJ, Scott MK, Shank RP, Vaught JL.
    J Med Chem; 1994 Apr 15; 37(8):1060-2. PubMed ID: 7909336
    [No Abstract] [Full Text] [Related]

  • 20. Neuroleptic binding to muscarinic M2 receptors of normal human heart in vitro and comparison with binding to M1 and dopamine D2 receptors of brain.
    Neeper R, Richelson E, Nelson A.
    Neuropharmacology; 1991 May 15; 30(5):527-9. PubMed ID: 1678146
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.